Metabotropic Glutamate Receptors and Interacting Proteins in Epileptogenesis

Curr Neuropharmacol. 2016;14(5):551-62. doi: 10.2174/1570159x14666160331142228.

Abstract

Neurotransmitter and receptor systems are involved in different neurological and neuropsychological disorders such as Parkinson's disease, depression, Alzheimer's disease and epilepsy. Recent advances in studies of signal transduction pathways or interacting proteins of neurotransmitter receptor systems suggest that different receptor systems may share the common signal transduction pathways or interacting proteins which may be better therapeutic targets for development of drugs to effectively control brain diseases. In this paper, we reviewed metabotropic glutamate receptors (mGluRs) and their related signal transduction pathways or interacting proteins in status epilepticus and temporal lobe epilepsy, and proposed some novel therapeutical drug targets for controlling epilepsy and epileptogenesis.

Publication types

  • Review

MeSH terms

  • Animals
  • Anticonvulsants / pharmacology
  • Anticonvulsants / therapeutic use
  • Epilepsy, Temporal Lobe / drug therapy
  • Epilepsy, Temporal Lobe / metabolism*
  • Excitatory Amino Acid Agents / pharmacology
  • Excitatory Amino Acid Agents / therapeutic use
  • Humans
  • Receptors, Metabotropic Glutamate / agonists
  • Receptors, Metabotropic Glutamate / antagonists & inhibitors
  • Receptors, Metabotropic Glutamate / metabolism*
  • Signal Transduction / drug effects
  • Signal Transduction / physiology
  • Status Epilepticus / drug therapy
  • Status Epilepticus / metabolism*

Substances

  • Anticonvulsants
  • Excitatory Amino Acid Agents
  • Receptors, Metabotropic Glutamate